These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26248494)

  • 1. Oral glucocorticoid pulse therapy for induction of treatment of canine pemphigus foliaceus - a comparative study.
    Bizikova P; Olivry T
    Vet Dermatol; 2015 Oct; 26(5):354-8, e76-7. PubMed ID: 26248494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged remission after immunosuppressive therapy in six dogs with pemphigus foliaceus.
    Olivry T; Bergvall KE; Atlee BA
    Vet Dermatol; 2004 Aug; 15(4):245-52. PubMed ID: 15305932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of oclacitinib compared to azathioprine in the management of canine pemphigus foliaceus: A retrospective analysis.
    Hernandez-Bures A; Bidot WA; Griffin CE; Rosenkrantz WS
    Vet Dermatol; 2023 Dec; 34(6):554-566. PubMed ID: 37700599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective evaluation of the steroid sparing effects of oral mycophenolate mofetil (MMF) as an adjunct immunosuppressant for the treatment of canine pemphigus foliaceus.
    Putra A; Austel M; Banovic F
    Vet Dermatol; 2022 Feb; 33(1):77-e24. PubMed ID: 34697841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of modified ciclosporin in the management of feline pemphigus foliaceus: a retrospective analysis.
    Irwin KE; Beale KM; Fadok VA
    Vet Dermatol; 2012 Oct; 23(5):403-e76. PubMed ID: 22731616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus.
    Kanwar AJ; Kaur S; Thami GP
    Dermatology; 2002; 204(3):228-31. PubMed ID: 12037452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose intravenous 'pulse' methylprednisone in the treatment of severe oropharyngeal pemphigus: a pilot study.
    Mignogna MD; Lo Muzio L; Ruoppo E; Fedele S; Lo Russo L; Bucci E
    J Oral Pathol Med; 2002 Jul; 31(6):339-44. PubMed ID: 12201245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feline pemphigus foliaceus in non-specialist veterinary practice: a retrospective analysis.
    Coyner K; Tater K; Rishniw M
    J Small Anim Pract; 2018 Sep; 59(9):553-559. PubMed ID: 29961990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are low doses of oral glucocorticoids as effective as high doses as the sole treatment for canine pemphigus foliaceus?
    Swales N; Place E; Barnard N; Foster A
    Vet Rec; 2019 Nov; 185(21):660-662. PubMed ID: 31780506
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris.
    Shahidi-Dadras M; Karami A; Toosy P; Shafiyan A
    Arch Iran Med; 2007 Jan; 10(1):1-6. PubMed ID: 17198445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
    Mentink LF; Mackenzie MW; Tóth GG; Laseur M; Lambert FP; Veeger NJ; Cianchini G; Pavlovic MD; Jonkman MF
    Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab in the management of juvenile pemphigus foliaceus.
    Loh TY; Paravar T
    Dermatol Online J; 2017 Jun; 23(6):. PubMed ID: 28633733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yearly reduction of glucocorticoid dose by 50% as tapering schedule achieves complete remission for 124 pemphigus vulgaris patients.
    Wang M; Gao Y; Peng Y; Zhao J; Chen X; Zhu X
    J Dermatol; 2016 Mar; 43(3):325-8. PubMed ID: 26332949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histopathological features of pemphigus foliaceus with and without eosinophilic infiltrates: a retrospective evaluation of 40 dogs.
    Vaughan DF; Clay Hodgin E; Hosgood GL; Bernstein JA
    Vet Dermatol; 2010 Apr; 21(2):166-74. PubMed ID: 20136786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metaflumizone-amitraz (Promeris)-associated pustular acantholytic dermatitis in 22 dogs: evidence suggests contact drug-triggered pemphigus foliaceus.
    Oberkirchner U; Linder KE; Dunston S; Bizikova P; Olivry T
    Vet Dermatol; 2011 Oct; 22(5):436-48. PubMed ID: 21418349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of prednisolone as monotherapy in the treatment of feline pemphigus foliaceus: a retrospective study of 37 cats.
    Simpson DL; Burton GG
    Vet Dermatol; 2013 Dec; 24(6):598-601, e143-4. PubMed ID: 24118463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polysulfated Glycosaminoglycan as a Novel, Adjunctive Therapy for Pemphigus Foliaceus in Three Dogs.
    Simpson A; Rosychuck R; Schissler J; Souza C
    J Am Anim Hosp Assoc; 2019; 55(6):318-322. PubMed ID: 31525095
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral cyclophosphamide for treatment of pemphigus vulgaris and foliaceus.
    Cummins DL; Mimouni D; Anhalt GJ; Nousari CH
    J Am Acad Dermatol; 2003 Aug; 49(2):276-80. PubMed ID: 12894077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-year treatment experience for pemphigus: retrospective study of 69 Chinese patients.
    Bai YX; Zhang LM; Xiao T; Chen HD
    Dermatol Ther; 2016; 29(2):84-7. PubMed ID: 27060935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.